Basic information Application Safety Supplier Related

Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]-

Basic information Application Safety Supplier Related

Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]- Basic information

Product Name:
Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]-
Synonyms:
  • Ipragliflozin Impurity A
  • Ipragliflozin-003
  • Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]-
  • Methyl 1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-alpha-D-glucopyranoside
  • (2S,3R,4S,5S,6R)-2-(3-(benzo[b]thiophen-2-ylMethyl)-4-fluorophenyl)-6-(hydroxyMethyl)-2-Methoxytetrahydro-2H-pyran-3,4,5-triol
  • Methyl 1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-α-D-glucopyranoside
  • Ipragliflozin impurity A (C7)
  • Methyl 1-C-[3-(1-benzothien-2-ylmethyl)-4-fluorophenyl]-alpha-glucopyranoside
CAS:
1034305-23-1
MF:
C22H23FO6S
MW:
434.48
Mol File:
1034305-23-1.mol
More
Less

Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]- Chemical Properties

storage temp. 
2-8°C(protect from light)
More
Less

Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]- Usage And Synthesis

Application

Methyl 1-C-[3-(benzo[B]thiophene-2-ylmethyl)-4-fluorophenyl]-ALPHA-D-glucopyranoside can be used as an analytical standard and reference, mainly in laboratory research and development processes and chemical production processes.

Synthesis

67-56-1

1034305-17-3

32469-28-6

1034305-23-1

A tetrahydrofuran solution of 0.9 M n-butylmagnesium chloride (0.9 M, 7.3 mL) was slowly added to toluene (18.0 mL) at -16 °C. Subsequently, n-hexane solution of n-butyllithium (2.66 M, 4.9 mL) was added dropwise at -12 °C and stirred for 16 min in the range of -12 to -15 °C. 2-(5-bromo-2-fluorobenzyl)benzo[b]thiophene (Compound I, 2.000 g) was dissolved in toluene (10.0 mL) and added dropwise to the reaction system at -12 to -15 °C, the dropwise process lasted for 1 hour. Next, a toluene solution (10.0 mL) of (3S,4S,5R,6R)-3,4,5-tris((trimethylmethylsilyl)oxy)-6-(((trimethylsilyl)oxy)methyl)tetrahydro-2H-pyran-2-one (Compound II, 3.197 g) was added dropwise to the reaction solution and stirred for 3 hours at -12 to -15 °C. Upon completion of the reaction, the mixture was poured into a methanol solution (10.0 mL) of methanesulfonic acid (3.0 mL) at 0 °C or lower, followed by stirring for 16 hours and 36 minutes at room temperature. The reaction mixture was quenched with an aqueous sodium carbonate solution of pH about 8. The organic layer was washed with saturated brine (10 mL, once), dried over anhydrous sodium sulfate, and extracted with ethyl acetate (50 mL, twice). After filtration, the solvent was removed by distillation under reduced pressure and the resulting residue was purified by silica gel column chromatography to afford the target product (2S,3R,4S,5S,6R)-2-(3-(benzo[b]thiophene-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)-2-methoxytetrahydro-2H-pyran-3,4,5triol (2.336 g, 86.4% yield).

References

[1] Patent: TW2016/2128, 2016, A. Location in patent: Paragraph 0024; 0025
[2] Patent: EP2105442, 2009, A1. Location in patent: Page/Page column 14

Methyl 1-C-[3-(benzo[b]thien-2-ylMethyl)-4-fluorophenyl]-Supplier

Anhui Lianchuang Biological Medicine Co.,Ltd
Tel
0551-68779238 18056025720
Email
sales3@lcywhx.com
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Chongqing Carechem Co.,Ltd.
Tel
18680818008/15802381793
Email
cqudgh@126.com
Shanghai Balmxy Pharmaceutical Co., Ltd
Tel
021-24206007 13764915196
Email
sales@balmxy.com
Shanghai YuLue Chemical Co., Ltd.
Tel
021-60345187 13671753212
Email
lzz841106@aliyun.com